# Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational Study

> **NCT07054229** · — · RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 480 (estimated)

## Conditions studied

- Microwave Ablation
- Contrast-enhanced Ultrasound
- Genetic and Molecular Diagnostics
- Papillary Thyroid Microcarcinoma

## Interventions

- **DRUG:** Contrast enhanced Ultrasound
- **GENETIC:** 88-gene panel for thyroid cancer

## Key facts

- **NCT ID:** NCT07054229
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07054229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07054229, "Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07054229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*